List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 1023 studies with search of: Alzheimer's Disease
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Genetic: CERE-110: Adeno-Associated Virus Delivery of NGF;   Procedure: Placebo Surgery
2 Recruiting Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Condition: Alzheimer's Disease
Interventions: Behavioral: Individualized management of AD including caregiver training;   Drug: Memantine
3 Completed
Has Results 		Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Varenicline;   Drug: Placebo
4 Completed Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: Placebo
5 Not yet recruiting Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Procedure: fMRI to detect MCI patients who will convert to Alzheimer's disease
6 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
7 Recruiting A Clinical Trial of Exendin-4 for the Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Exendin-4 (Exenatide)
8 Completed Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)
Condition: Alzheimer's Disease
Intervention:
9 Completed Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 0.1 mg/kg;   Biological: PF-04360365 0.5 mg/kg;   Biological: PF-04360365 1 mg/kg;   Drug: Placebo;   Biological: PF-04360365 3 mg/kg;   Biological: PF-04360365 8.5 mg/kg
10 Recruiting Alzheimer's Disease Neuroimaging Initiative 2
Conditions: Mild Cognitive Impairment (MCI);   Alzheimer's Disease
Intervention:
11 Recruiting Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: donepezil
12 Unknown † Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Bryostatin for Injection;   Drug: Placebo
13 Active, not recruiting Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Central Nervous System Diseases;   Cognition
Interventions: Drug: EVP-6124;   Drug: Placebo
14 Completed Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
Condition: Alzheimer's Disease
Intervention:
15 Active, not recruiting Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
16 Recruiting Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia;   Memory Loss;   Cognitive Impairment
Intervention: Drug: ladostigil hemitartrate
17 Completed
Has Results 		Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
18 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
19 Completed A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
Condition: Alzheimer's Disease
Interventions: Other: MRI;   Other: FDG-PET
20 Completed Effect of LY450139 on the Long Term Progression of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY450139;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services